AddLife Development AB is a Swedish AB based in Stockholm, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 1994, the company has 3 employees and reported revenue of SEK 98.3m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Föremål för bolagets verksamhet är att marknadsföra, sälja och distribuera laboratorieprodukter avsedda för in vitro-metoder nationellt och internationellt, att tillhandahålla tjänster inom detta område samt inneha och förvalta företag, ävensom driva annnan därmed förenlig verksamhet.
In its most recent annual report (2024), AddLife Development AB reported revenue of SEK 98.3m, an increase of 10% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 326.7m, and the EBITDA margin stood at -2.7%.
At the end of 2024, equity financed 26.1% of the balance sheet, and current assets covered short-term debt 0.5 times.
Frequently asked questions
What is the Org number of AddLife Development AB?
AddLife Development AB is registered with Bolagsverket / SCB under Org 5564908373.
What is the revenue of AddLife Development AB?
AddLife Development AB reported revenue of SEK 98.3m in 2024.
How many employees does AddLife Development AB have?
AddLife Development AB employs 3 people as of the latest annual report.
Who is the CEO of AddLife Development AB?
Anna Christina Rubenhag is the CEO of AddLife Development AB, in role since 2022.
Who is the chairman of AddLife Development AB?
Fredrik Olof Dalborg chairs the board of AddLife Development AB, in role since 2022.
Where is AddLife Development AB headquartered?
AddLife Development AB's registered address is Birger Jarlsgatan 43.
